ClinicalTrials.govpublic full text
Immunobridging/Maintenance Therapy Versus Non-bridging Therapy in CAR-T Therapy for Low-risk R/R B-NHL
b-nhl, cart therapy, zanubrutinib, maintenance, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 902109
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.